{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:40:11Z","timestamp":1751449211421,"version":"3.41.0"},"reference-count":32,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BLCTT"],"DOI":"10.2147\/blctt.s548242","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:10:11Z","timestamp":1751447411000},"page":"77-83","source":"Crossref","is-referenced-by-count":0,"title":["Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R\/R AML [Podcast]"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Amer M","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.5858\/arpa.2016-0504-CP","volume":"141","author":"Arber","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","volume":"21","author":"Pollyea","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"ref4","first-page":"vi138","volume":"24 Suppl 6","author":"Heuser","year":"2020","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/JCO.18.01468","volume":"37","author":"de Haas","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1182\/bloodadvances.2020001920","volume":"4","author":"Sekeres","year":"2020","journal-title":"Blood Adv"},{"key":"ref7","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Acute Myeloid Leukemia. Version 2.2025. National Comprehensive Cancer Network; 2025. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf. Accessed March 10, 2025."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.blre.2017.01.003","volume":"31","author":"Percival","year":"2017","journal-title":"Blood Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41375-024-02246-2","volume":"38","author":"Fruchtman","year":"2024","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.6004\/jadpro.2019.10.5.7","volume":"10","author":"Merchant","year":"2019","journal-title":"J Adv Pract Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1182\/blood-2022-167330","volume":"140","author":"Cortes","year":"2022","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.3390\/cancers14123012","volume":"14","author":"Messina","year":"2022","journal-title":"Cancers"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41408-021-00497-1","volume":"11","author":"Issa","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/bloodadvances.2022009411","volume":"7","author":"de Botton","year":"2023","journal-title":"Blood Adv"},{"key":"ref16","unstructured":"Rigel Pharms (2022) REZLIDHIA\u2122 (olutasidenib) capsules, for oral use [package insert]. South San Francisco, CA: Rigel Pharms; 2022."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"DiNardo","year":"2018","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"Montesinos","year":"2022","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/10428194.2024.2333451","volume":"65","author":"Cortes","year":"2024","journal-title":"Leuk Lymphoma"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.3390\/cancers15194767","volume":"15","author":"Woods","year":"2023","journal-title":"Cancers"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.2024024008","volume":"145","author":"Issa","year":"2025","journal-title":"Blood"},{"key":"ref22","first-page":"435","volume":"9","author":"Myers","year":"2018","journal-title":"J Adv Pract Oncol"},{"key":"ref23","unstructured":"IDHIFA\u00ae (enasidenib tablets, for oral use) [package insert]. Boston, MA: Servier Pharmaceuticals LLC; 2025."},{"key":"ref24","unstructured":"TIBSOVO\u00ae (ivosidenib tablets) [package insert]. Boston, MA: Servier Pharmaceuticals LLC; 2023."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.31557\/APJCP.2020.21.3.721","volume":"21","author":"ElNahass","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.6004\/jnccn.2025.0013","volume":"23","author":"Greenberg","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1182\/blood-2024-198504","volume":"144","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/1078-0432.CCR-24-2196","volume":"31","author":"Woods","year":"2025","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1182\/bloodadvances.2023009854","volume":"7","author":"Venugopal","year":"2023","journal-title":"Blood Adv"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1200\/JCO.2024.42.16_suppl.6528","volume":"42","author":"Cortes","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.3390\/cancers15184618","volume":"15","author":"Ucciero","year":"2023","journal-title":"Cancers"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"100016","DOI":"10.1016\/j.bneo.2024.100016","volume":"1","author":"Madarang","year":"2024","journal-title":"Blood Neoplasia"}],"container-title":["Blood and Lymphatic Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/104427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/104427","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:10:13Z","timestamp":1751447413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/advancing-aml-treatment-evidence-based-regimens-and-guideline-updates--peer-reviewed-fulltext-article-BLCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2147\/blctt.s548242","relation":{},"ISSN":["1179-9889"],"issn-type":[{"value":"1179-9889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}